![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
In c6137 transmitted at 7:30e today, the news release contained clerical errors in the Consolidated Statements of Loss. The title of the press release also referred to fourth quarter results when...
TORONTO, July 21 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. (Lorus), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies...
TORONTO, July 16 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development...
TORONTO, July 9 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development...
- Study also points to potential of pre-treatment R2 levels as a possible predictor of clinical activity - TORONTO, July 2 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP...
- Orphan Drug designation by the EMEA demonstrates the potential of LOR-2040 to provide significant therapeutic benefit to AML patients - TORONTO, June 23 /PRNewswire-FirstCall/ -- Lorus...
TORONTO, May 6 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ("Lorus" or the "Company") (TSX: LOR; AMEX: LRP), a biopharmaceutical company specializing in the research and development of...
TORONTO, May 5 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company dedicated in the research, development and commercialization of...
TORONTO, April 22 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical company specializing in the research and development of pharmaceutical products and...
- Scientific Presentation at the 99th Annual Meeting of the American Association for Cancer Research (AACR) - TORONTO, April 16 /PRNewswire-FirstCall/ -- Lorus Therapeutics Inc. ("Lorus") (TSX:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions